Antigen-Specific Tolerance as a Therapy for Experimental Autoimmune Encephalomyelitis (Q35173096)

6 August 2017

1 reference

title

Antigen-specific tolerance as a therapy for experimental autoimmune encephalomyelitis (English)

1 reference

6 August 2017

Antigen-Specific Tolerance as a Therapy for Experimental Autoimmune Encephalomyelitis (English)

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

experimental autoimmune encephalomyelitis

23 November 2023

main subject

1 reference

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

23 November 2023

author name string

S. D. Miller

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:1285061

9 September 2022

L. J. Tan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:1285061

9 September 2022

L. Pope

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:1285061

9 September 2022

B. L. McRae

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:1285061

9 September 2022

W. J. Karpus

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:1285061

9 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1285061

9 September 2022

publication date

1 January 1992

1 reference

full work available at URL

6 August 2017

http://www.tandfonline.com/doi/pdf/10.3109/08830189209061791

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

International Reviews of Immunology

23 November 2023

published in

1 reference

6 August 2017

volume

9

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

203-222

1 reference

Autoimmune demyelination in the central nervous system

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Transfer of allergic encephalomyelitis in rats by means of lymph node cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Immunomodulation of experimental allergic encephalomyelitis by antibodies to the antigen–Ia complex

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Prevention and treatment of murine experimental allergic encephalomyelitis with T cell receptor V beta-specific antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Vaccination against experimental autoimmune encephalomyelitis using a subencephalitogenic dose of autoimmune effector cells (1). Characteristics of vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Antigen-specific therapy of experimental allergic encephalomyelitis by soluble class II major histocompatibility complex-peptide complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Monoclonal antibody-induced inhibition of relapsing EAE in SJL/J mice correlates with inhibition of neuroantigen-specific cell-mediated immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

The induction of cell-mediated immunity and tolerance with protein antigens coupled to syngeneic lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Two minor determinants of myelin basic protein induce experimental allergic encephalomyelitis in SJL/J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Characterization of a major encephalitogenic T cell epitope in SJL/J mice with synthetic oligopeptides of myelin basic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Localization of an enciphalitogenic epitope for the SJL mouse in the N-terminal region of myelin basic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

The major site of guinea-pig myelin basic protein encephalitogenic in Lewis rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

The N- and C-terminal boundaries of myelin basic protein determinants required for encephalitogenic and proliferative responses of Lewis rat T cells☆☆☆

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Antigen-specific inhibition of the adoptive transfer of experimental autoimmune encephalomyelitis in Lewis rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Specific Immunoregulation of the Induction and Effector Stages of Relapsing EAE via Neuroantigen-Specific Tolerance Induction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

T cell sensitization to proteolipid protein in myelin basic protein-induced relapsing experimental allergic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Alterations in T cell antigen specificity and class II restriction during the course of chronic relapsing experimental allergic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. III. Failure of neuroantigen-specific immune tolerance to affect the clinical course of demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

The induction of hapten-specific T cell tolerance using hapten-modified lymphoid membranes II. Relative roles of suppressor T cells and clone inhibition in the tolerant state

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Clonal anergy induced in mature V beta 6 T lymphocytes on immunizing Mls-1b mice with Mls-1a expressing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

The specific selection of recirculating lymphocytes by antigen in normal and preimmunized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Effect of recent antigen priming on adoptive immune responses. II. Specific unresponsiveness of circulating lymphocytes from mice primed with heterologous erythrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Genetic control of specific immune suppression. IV. Responsiveness to the random copolymer L-glutamic acid(50)-L-tyrosine(50) induced in BALB/c mice by cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

T-cell unresponsiveness in vivo and in vitro: fine specificity of induction and molecular characterization of the unresponsive state

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Serial adoptive transfer of murine experimental allergic encephalomyelitis: successful transfer is dependent on active disease in the donor.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Effects of blocking helper T cell induction in vivo with anti-Ia antibodies. Possible role of I-A/E hybrid molecules as restriction elements

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

In vivo effects of antibodies to immune response gene products: prevention of experimental allergic encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Induction of tolerance by monoclonal antibody therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Long-term humoral unresponsiveness in vivo, induced by treatment with monoclonal antibody against L3T4.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Predominant expression of a T cell receptor V beta gene subfamily in autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Protection from experimental allergic encephalomyelitis conferred by a monoclonal antibody directed against a shared idiotype on rat T cell receptors specific for myelin basic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

The V-region disease hypothesis: evidence from autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

T-cell receptor peptide immunization leads to enhanced and chronic experimental allergic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Trials of vaccination against experimental autoimmune uveoretinitis with a T-cell receptor peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Limited heterogeneity of rearranged T-cell receptor V alpha transcripts in brains of multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Shared human T cell receptor V beta usage to immunodominant regions of myelin basic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Inhibition of T cell activation by MHC blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Prevention of experimental encephalomyelitis with peptides that block interaction of T cells with major histocompatibility complex proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Antigen-driven bystander suppression after oral administration of antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Vaccination against autoimmune encephalomyelitis with T-lymphocite line cells reactive against myelin basic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Myelin proteolipid protein induces demyelinating disease in mice

21 January 2018

6

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein

23 November 2023

9

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

The adoptive transfer of chronic relapsing experimental allergic encephalomyelitis with lymph node cells sensitized to myelin proteolipid protein

23 November 2023

12

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

T lymphocyte lines producing or vaccinating against autoimmune encephalomyelitis (EAE). Functional activation induces peanut agglutinin receptors and accumulation in the brain and thymus of line cells

23 November 2023

59

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

T-lymphocyte entry into the central nervous system

23 November 2023

61

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Adoptive transfer of murine chronic-relapsing autoimmune encephalomyelitis. Analysis of basic protein-reactive cells in lymphoid organs and nervous system of donor and recipient animals

23 November 2023

66

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T-cell subset marker

23 November 2023

71

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Vaccination against autoimmune encephalomyelitis (EAE): Attenuated autoimmune T lymphocytes confer resistance to induction of active EAE but not to EAE mediated by the intact T lymphocyte line

23 November 2023

75

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis

23 November 2023

76

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells

23 November 2023

77

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Both rat and mouse T cell receptors specific for the encephalitogenic determinant of myelin basic protein use similar V alpha and V beta chain genes even though the major histocompatibility complex and encephalitogenic determinants being recognized

23 November 2023

79

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

Studies of V beta 8 T cell receptor peptide treatment in experimental autoimmune encephalomyelitis

23 November 2023

83

1 reference

https://api.crossref.org/works/10.3109/08830189209061791

23 November 2023

Identifiers

1 reference

6 August 2017

1 reference